223 related articles for article (PubMed ID: 29197671)
21. The 1,10-Phenanthroline Ligand Enhances the Antiproliferative Activity of DNA-Intercalating Thiourea-Pd(II) and -Pt(II) Complexes Against Cisplatin-Sensitive and -Resistant Human Ovarian Cancer Cell Lines.
Marverti G; Gozzi G; Lauriola A; Ponterini G; Belluti S; Imbriano C; Costi MP; D'Arca D
Int J Mol Sci; 2019 Dec; 20(24):. PubMed ID: 31817267
[TBL] [Abstract][Full Text] [Related]
22. Anticancer activity of new imidazole derivative of 1R,2R-diaminocyclohexane palladium and platinum complexes as DNA fluorescent probes.
Hadian Rasanani S; Eslami Moghadam M; Soleimani E; Divsalar A; Ajloo D; Tarlani A; Amiri M
J Biomol Struct Dyn; 2018 Sep; 36(12):3058-3076. PubMed ID: 29027501
[TBL] [Abstract][Full Text] [Related]
23. Necrosis-Inducing High-Valent Oxo-Rhenium(V) Complexes with Potent Antitumor Activity: Synthesis, Aquation Chemistry, Cisplatin Cross-Resistance Profile, and Mechanism of Action.
Das S; Joshi P; Patra M
Inorg Chem; 2023 Dec; 62(48):19720-19733. PubMed ID: 37974075
[TBL] [Abstract][Full Text] [Related]
24. para-Sulfonatocalix[4]arene and polyamidoamine dendrimer nanocomplexes as delivery vehicles for a novel platinum anticancer agent.
Pang CT; Ammit AJ; Ong YQE; Wheate NJ
J Inorg Biochem; 2017 Nov; 176():1-7. PubMed ID: 28810174
[TBL] [Abstract][Full Text] [Related]
25. Mixed copper-platinum complex formation could explain synergistic antiproliferative effect exhibited by binary mixtures of cisplatin and copper-1,10-phenanthroline compounds: An ESI-MS study.
Pivetta T; Lallai V; Valletta E; Trudu F; Isaia F; Perra D; Pinna E; Pani A
J Inorg Biochem; 2015 Oct; 151():107-14. PubMed ID: 26021964
[TBL] [Abstract][Full Text] [Related]
26. Model platinum nucleobase and nucleoside complexes and antitumor activity: X-ray crystal structure of [PtIV(trans-1R,2R-diaminocyclohexane)trans-(acetate)2(9-ethylguanine)Cl]NO3.H2O.
Ali MS; Khan SR; Ojima H; Guzman IY; Whitmire KH; Siddik ZH; Khokhar AR
J Inorg Biochem; 2005 Mar; 99(3):795-804. PubMed ID: 15708801
[TBL] [Abstract][Full Text] [Related]
27. Cytotoxic platinum(II) intercalators that incorporate 1R,2R-diaminocyclopentane.
Garbutcheon-Singh KB; Leverett P; Myers S; Aldrich-Wright JR
Dalton Trans; 2013 Jan; 42(4):918-26. PubMed ID: 23018340
[TBL] [Abstract][Full Text] [Related]
28. Platinum(IV) complexes conjugated with phenstatin analogue as inhibitors of microtubule polymerization and reverser of multidrug resistance.
Huang X; Huang R; Gou S; Wang Z; Liao Z; Wang H
Bioorg Med Chem; 2017 Sep; 25(17):4686-4700. PubMed ID: 28728896
[TBL] [Abstract][Full Text] [Related]
29. Modulatory effect of axial and equatorial ligands on antitumor activities of trans-1R,2R-diaminocyclohexane platinum(IV) complexes.
Siddik ZH; al-Baker S; Thai G; Khokhar AR
Anticancer Drug Des; 1994 Apr; 9(2):139-51. PubMed ID: 8166929
[TBL] [Abstract][Full Text] [Related]
30. Dinuclear platinum anticancer complexes with fluorescent N,N'-bis(aminoalkyl)-1,4-diaminoanthraquinones: cellular processing in two cisplatin-resistant cell lines reflects the differences in their resistance profiles.
Kalayda GV; Jansen BA; Wielaard P; Tanke HJ; Reedijk J
J Biol Inorg Chem; 2005 May; 10(3):305-15. PubMed ID: 15824924
[TBL] [Abstract][Full Text] [Related]
31. Cytotoxic malonate platinum(II) complexes with 1,2,4-triazolo[1,5-a]pyrimidine derivatives: structural characterization and mechanism of the suppression of tumor cell growth.
Łakomska I; Hoffmann K; Wojtczak A; Sitkowski J; Maj E; Wietrzyk J
J Inorg Biochem; 2014 Dec; 141():188-197. PubMed ID: 25277461
[TBL] [Abstract][Full Text] [Related]
32. A Cytostatic Ruthenium(II)-Platinum(II) Bis(terpyridyl) Anticancer Complex That Blocks Entry into S Phase by Up-regulating p27(KIP1).
Ramu V; Gill MR; Jarman PJ; Turton D; Thomas JA; Das A; Smythe C
Chemistry; 2015 Jun; 21(25):9185-97. PubMed ID: 25950156
[TBL] [Abstract][Full Text] [Related]
33. Potent Chlorambucil-Platinum(IV) Prodrugs.
Aputen AD; Elias MG; Gilbert J; Sakoff JA; Gordon CP; Scott KF; Aldrich-Wright JR
Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142383
[TBL] [Abstract][Full Text] [Related]
34. Novel copper(II) complexes as new promising antitumour agents. A crystal structure of [Cu(1,10-phenanthroline-5,6-dione)2(OH2)(OClO3)](ClO4).
Pivetta T; Trudu F; Valletta E; Isaia F; Castellano C; Demartin F; Tuveri R; Vascellari S; Pani A
J Inorg Biochem; 2014 Dec; 141():103-113. PubMed ID: 25238635
[TBL] [Abstract][Full Text] [Related]
35. Study on the cytotoxic activity of platinum(II) complexes of (1R,2R)-N(1)-cyclopentyl-1,2-cyclohexanediamine with substituted malonate derivatives.
Zhou Z; Chen F; Xu G; Gou S
Bioorg Med Chem Lett; 2016 Jan; 26(2):322-327. PubMed ID: 26711148
[TBL] [Abstract][Full Text] [Related]
36. In vitro evaluation of the enantiomeric R- and S-1,1'-binaphthyl-2,2'-diaminodichlorido-Pt(ii) complexes in human Burkitt lymphoma cells: emphasis on cellular accumulation, cytotoxicity, DNA binding, and ability to induce apoptosis.
Sørensen BH; Werth P; Lambert IH; Bednarski PJ
Metallomics; 2018 Feb; 10(2):323-336. PubMed ID: 29333543
[TBL] [Abstract][Full Text] [Related]
37. A Potential Bone-Targeting Hypotoxic Platinum(II) Complex with an Unusual Cytostatic Mechanism toward Osteosarcoma Cells.
Zhang Z; Zhu Z; Luo C; Zhu C; Zhang C; Guo Z; Wang X
Inorg Chem; 2018 Mar; 57(6):3315-3322. PubMed ID: 29513007
[TBL] [Abstract][Full Text] [Related]
38. Synthesis of Ag(I) camphor sulphonylimine complexes and assessment of their cytotoxic properties against cisplatin-resistant A2780cisR and A2780 cell lines.
Cardoso JMS; Correia I; Galvão AM; Marques F; Carvalho MFNN
J Inorg Biochem; 2017 Jan; 166():55-63. PubMed ID: 27835775
[TBL] [Abstract][Full Text] [Related]
39. Rational design of dicarboxylato platinum(II) complexes with purine-mimetic ligands as novel anticancer agents.
Hoffmann K; Wiśniewska J; Wojtczak A; Sitkowski J; Denslow A; Wietrzyk J; Jakubowski M; Łakomska I
J Inorg Biochem; 2017 Jul; 172():34-45. PubMed ID: 28477537
[TBL] [Abstract][Full Text] [Related]
40. Gene-specific repair of Pt/DNA lesions and induction of apoptosis by the oral platinum drug JM216 in three human ovarian carcinoma cell lines sensitive and resistant to cisplatin.
O'Neill CF; Koberle B; Masters JR; Kelland LR
Br J Cancer; 1999 Dec; 81(8):1294-303. PubMed ID: 10604725
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
